Synchron has developed a minimally invasive brain-computer interface capable of controlling devices like Apple Vision Pro, and it has reached the one-year milestone without serious adverse effects to ...
ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results